Christopher Yea

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Benjamin L. Palleiko, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christopher Yea:

Company Role Class Num Shares Value Price $ Report Date Ownership
KalVista Pharmaceuticals, Inc. CHIEF DEVELOPMENT OFFICER Common Stock 223,508 $3,006,406 $13.45 24 Nov 2025 Direct
KalVista Pharmaceuticals, Inc. CHIEF DEVELOPMENT OFFICER Restricted Stock Unit 31,250 $399,108 $9.82 22 Nov 2025 Direct
KalVista Pharmaceuticals, Inc. CHIEF DEVELOPMENT OFFICER Employee Stock Option (Right to Buy) 0 20 Nov 2025 Direct

Insider Reports Filed by Christopher Yea

Symbol Company Period Transactions Value $ Form Type Role Filing Time
KALV KalVista Pharmaceuticals, Inc. 21 Nov 2025 5 -$58,256 4 CHIEF DEVELOPMENT OFFICER 26 Nov 2025, 18:49
KALV KalVista Pharmaceuticals, Inc. 20 Nov 2025 2 +$376 4 CHIEF DEVELOPMENT OFFICER 21 Nov 2025, 16:07
KALV KalVista Pharmaceuticals, Inc. 17 Nov 2025 4 -$38,848 4 CHIEF DEVELOPMENT OFFICER 19 Nov 2025, 16:11
KALV KalVista Pharmaceuticals, Inc. 22 Aug 2025 3 -$26,223 4 CHIEF DEVELOPMENT OFFICER 26 Aug 2025, 19:59
KALV KalVista Pharmaceuticals, Inc. 21 Aug 2025 3 -$31,232 4 CHIEF DEVELOPMENT OFFICER 25 Aug 2025, 19:46
KALV KalVista Pharmaceuticals, Inc. 17 Aug 2025 4 -$34,932 4 CHIEF DEVELOPMENT OFFICER 19 Aug 2025, 16:27
KALV KalVista Pharmaceuticals, Inc. 08 Jul 2025 2 -$474,698 4 CHIEF DEVELOPMENT OFFICER 10 Jul 2025, 20:50
KALV KalVista Pharmaceuticals, Inc. 22 May 2025 3 -$21,782 4 CHIEF DEVELOPMENT OFFICER 27 May 2025, 16:05
KALV KalVista Pharmaceuticals, Inc. 21 May 2025 3 -$27,516 4 CHIEF DEVELOPMENT OFFICER 23 May 2025, 16:25
KALV KalVista Pharmaceuticals, Inc. 17 May 2025 4 -$30,791 4 CHIEF DEVELOPMENT OFFICER 20 May 2025, 19:28
KALV KalVista Pharmaceuticals, Inc. 21 Feb 2025 4 -$19,218 4 CHIEF DEVELOPMENT OFFICER 25 Feb 2025, 20:36
KALV KalVista Pharmaceuticals, Inc. 17 Feb 2025 4 -$25,553 4 CHIEF DEVELOPMENT OFFICER 19 Feb 2025, 20:47
KALV KalVista Pharmaceuticals, Inc. 22 Nov 2024 3 -$19,378 4 CHIEF DEVELOPMENT OFFICER 27 Nov 2024, 20:43
KALV KalVista Pharmaceuticals, Inc. 17 Nov 2024 5 -$66,573 4 CHIEF DEVELOPMENT OFFICER 19 Nov 2024, 19:18
KALV KalVista Pharmaceuticals, Inc. 22 Aug 2024 3 -$23,758 4 CHIEF DEVELOPMENT OFFICER 26 Aug 2024, 19:58
KALV KalVista Pharmaceuticals, Inc. 17 Aug 2024 5 -$85,318 4 CHIEF DEVELOPMENT OFFICER 21 Aug 2024, 21:25
KALV KalVista Pharmaceuticals, Inc. 22 May 2024 1 $0 4 CHIEF DEVELOPMENT OFFICER 24 May 2024, 16:10
KALV KalVista Pharmaceuticals, Inc. 17 May 2024 6 -$136,586 4 CHIEF DEVELOPMENT OFFICER 21 May 2024, 17:55
KALV KalVista Pharmaceuticals, Inc. 17 Feb 2024 6 -$170,124 4 CHIEF DEVELOPMENT OFFICER 21 Feb 2024, 21:48
KALV KalVista Pharmaceuticals, Inc. 14 Feb 2024 1 -$598,661 4 CHIEF DEVELOPMENT OFFICER 16 Feb 2024, 16:18
KALV KalVista Pharmaceuticals, Inc. 11 Feb 2024 2 $0 4 CHIEF DEVELOPMENT OFFICER 13 Feb 2024, 09:11
KALV KalVista Pharmaceuticals, Inc. 17 Nov 2023 5 -$58,535 4 Chief Development Officer 21 Nov 2023, 16:32
KALV KalVista Pharmaceuticals, Inc. 17 Aug 2023 5 -$76,624 4 Chief Development Officer 21 Aug 2023, 21:06
KALV KalVista Pharmaceuticals, Inc. 17 Feb 2023 1 $0 4/A Chief Development Officer 22 May 2023, 21:40
KALV KalVista Pharmaceuticals, Inc. 11 Jan 2023 5 -$26,416 4 Chief Development Officer 19 May 2023, 21:20
KALV KalVista Pharmaceuticals, Inc. 21 Nov 2022 3 -$6,196 4 Chief Development Officer 21 Nov 2022, 15:21
KALV KalVista Pharmaceuticals, Inc. 17 Aug 2022 3 -$17,130 4 Chief Development Officer 19 Aug 2022, 17:16
KALV KalVista Pharmaceuticals, Inc. 17 May 2022 2 $0 4 Chief Development Officer 19 May 2022, 16:57
KALV KalVista Pharmaceuticals, Inc. 01 Nov 2021 1 -$90,328 4 Chief Development Officer 03 Nov 2021, 16:56
KALV KalVista Pharmaceuticals, Inc. 02 Aug 2021 1 -$102,578 4 Chief Development Officer 04 Aug 2021, 19:55
KALV KalVista Pharmaceuticals, Inc. 26 May 2021 1 $0 4 Chief Development Officer 28 May 2021, 17:26